Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC)
Year: 2013
Type: conference-paper
Authors: Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, David Brown, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono, Vesa Kataja, Christine Desmedt, Martine Piccart, Sibylle Loibl, Michael Untch, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W767052336